Tower Research Capital (TRC)’s DTRT Health Acquisition Corp. Class A Common Stock DTRT Stock Holding History

Tower Research Capital (TRC)’s Portfolio DTRT Stock Details DTRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-146	Closed	-$2K	–	6713
2022 Q4	$2K	Buy	+146	New	+$1.5K	﹤0.01%	5518
2022 Q1	–	Sell	-483	Closed	-$5K	–	6947
2021 Q4	$5K	Buy	+483	New	+$4.82K	﹤0.01%	5246

Tower Research Capital (TRC)'s DTRT Position: Q1 2023 in Review

Tower Research Capital (TRC) sold out of DTRT Health Acquisition Corp. Class A Common Stock (DTRT) in Q1 2023, closing a stake of 146 shares — an estimated $2K sold.

Tower Research Capital (TRC) first reported a position in DTRT in Q4 2021 and held it in 2 quarters. The position peaked at $5K in Q4 2021. 0 funds tracked by Wall St. Rank hold DTRT as of Q1 2023.

Tower Research Capital (TRC) reported no remaining DTRT Health Acquisition Corp. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
Tower Research Capital (TRC) sold 146 DTRT Health Acquisition Corp. Class A Common Stock shares in Q1 2023, an estimated $2K.
Tower Research Capital (TRC) first reported a position in DTRT Health Acquisition Corp. Class A Common Stock in Q4 2021 and held it in 2 quarters.
Tower Research Capital (TRC)'s DTRT Health Acquisition Corp. Class A Common Stock position peaked at $5K in Q4 2021.
0 funds tracked by Wall St. Rank held DTRT Health Acquisition Corp. Class A Common Stock as of Q1 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.